Prednisolone Urinary Excretion Kinetics
NCT05300490 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-03-20
Summary
The urinary elimination kinetics of glucocorticoids after intra-articular injection is very poorly documented. It is estimated that glucocorticoids may be present in the urine up to 6 weeks after intra-articular injection. However, this is not supported by any scientific literature. Despite this lack of evidence, in doping control practice, any presence of glucocorticoids in urine is accepted when the athlete provides evidence of an intra-articular injection that took place less than 6 weeks prior to the doping control. Many doping cases are open to challenge because they are based solely on measurements of prednisolone concentrations and its blood esterase product, prednisone. In order to demonstrate the use of prednisolone for doping purposes (systemic and not intra-articular use), it is therefore necessary to know the urinary elimination kinetics of prednisolone and prednisone, as well as the evolution of the concentration ratio between these 2 molecules.
Conditions
- Articular Cartilage Disorder of Knee
Interventions
- DRUG
-
Prednisolone
In this routine care study, all patients will receive a joint injection of prednisolone at a dose left to the discretion of the physician. The urinary excretion kinetics of this product and its metabolites will then be followed at different times. An association with metabolic genetic profile will be done.
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-31
- Primary Completion
- 2023-11-30
- Completion
- 2024-01-01
Countries
- France
Study Locations
More Related Trials
-
Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
NCT00369538 ·Status: SUSPENDED ·Phase: PHASE4
-
Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
NCT00335413 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis
NCT01690039 ·Status: COMPLETED
-
Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension
NCT00005394 ·Status: COMPLETED
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Lowering Uric Acid in Live Kidney Donors
NCT03353298 ·Status: COMPLETED ·Phase: PHASE2
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
NCT06190158 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
NCT06047912 ·Status: UNKNOWN
-
Efficacy of Diuretics in Kidney Disease
NCT04542304 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure
NCT00953303 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long Term Tapering or Standard Steroids for Nephrotic Syndrome
NCT00308321 ·Status: UNKNOWN ·Phase: PHASE4
-
Hydrochlorothiazide for Kidney Stone Recurrence Prevention
NCT03057431 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.
NCT04393493 ·Status: COMPLETED ·Phase: PHASE2
-
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
NCT03746002 ·Status: TERMINATED ·Phase: PHASE4
-
Diuretic Use in Hemodialysis Patients With Residual Renal Function
NCT05915286 ·Status: TERMINATED ·Phase: PHASE4
-
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
NCT00568178 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
NCT01750294 ·Status: COMPLETED ·Phase: PHASE4
-
Allopurinol for Renal Transplant Associated Hypertension in Children
NCT00288171 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Ciclosporin A Preconditioning for Renal Artery Stenosis
NCT03382301 ·Status: COMPLETED ·Phase: PHASE2
-
Loop Diuretics in Chronic Kidney Disease
NCT00478543 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
NCT01073189 ·Status: WITHDRAWN ·Phase: PHASE4
-
Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
NCT03201939 ·Status: TERMINATED ·Phase: PHASE2
-
Pre-ESRD Syndrome in High Risk African Americans
NCT00224939 ·Status: TERMINATED ·Phase: NA
-
Diuretic Testing in Chronic Kidney Disease
NCT06841692 ·Status: RECRUITING ·Phase: NA
-
A Study of Ultra High Dose Diuretics to Treat Heart Failure
NCT06036914 ·Status: COMPLETED ·Phase: PHASE2